Join us on 4 December to learn more about the science of liquid biopsies from leaders in the field
Click the button below to register
Liquid biopsies are a relatively new technique offering a revolutionary approach to cancer detection and monitoring. The minimally invasive method analyses biomarkers within bodily fluids such as blood and serum without the requirement for traditional tissue biopsies, reducing patient recovery time and streamlining the process with the latest technology. Liquid biopsies can allow scientists to identify cancer at an early stage, track tumour progression, assess treatment effectiveness and even enable personalised treatment plans.
In this hour-long, interactive webinar you will hear from two world-leading experts shaping the future of liquid biopsy science. Catherine Alix-Panabières is a globally renowned leader in the field of liquid biopsies. She will cover the concept of liquid biopsy as it stands in 2024 – including its history and how the technique has evolved – as well as focussing on the clinical relevance and application of circulating tumour cells. You will also hear from Matthew Baker, who is the co-founder and CEO of a company revolutionising liquid biopsy techniques by using AI to enable earlier detection of brain tumours.
This webinar promises to be informative and insightful, and will be useful for both industry experts and those working in related fields. Join us to learn how scientists are paving the way for liquid biopsies to become a standard tool shaping the future of cancer care, promising to improve cancer diagnosis, treatment and patient outcomes. You will also have the opportunity to ask questions to our speakers during the webinar.
Please note: Closed captions are available on this webinar.
No comments yet